← Evidence library

BIB_415

Selenium & skin-cancer — Filippini/Vinceti 2025 J Trace Elem Med Biol meta-analysis: fills a REAL GAP (zero prior selenium content in the brief despite the patient being on a multi-supplement stack + elevated NMSC co-risk). KEY ACTIONABLE: in RANDOMISED/experimental studies, selenium SUPPLEMENTATION increased squamous-cell-carcinoma risk (RR 1.25, 95% CI 1.04–1.49, significant) and melanoma non-significantly but in the harmful direction (RR 1.24, 95% CI 0.57–2.68); no BCC effect. → AVOID selenium supplements / selenium-containing "immune/antioxidant" products; dietary selenium fine. Joins the …

Evidence grade

B

Tier

1 (J Trace Elem Med Biol — peer-reviewed systematic review/dose-response meta-an

Cited by tasks

5a, 10, 13, 13a, 26

Identifiers

DOI:10.1016/j · PMID:40674897

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_415/findings.md (research corpus). This page is a short context summary — not individualised medical advice.